cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.22316869.v1
title: Supplementary Material for: Risk of psychiatric disorders in patients with psoriasis prescribed acitretin versus disease-modifying antirheumatic drugs: a nationwide matched cohort study

description: Background: Acitretin has been linked to the development of psychiatric disturbance. Objectives: To assess the psychiatric hazards in patients with psoriasis prescribed acitretin compared with those prescribed disease-modifying antirheumatic drugs (DMARDs). Methods: This is a nationwide matched cohort study. From Taiwan’s National Health Insurance Research Database, Adult patients with psoriasis between 1997 and 2013 were screened. Patients prescribed acitretin for at least 30 days per year on average (acitretin cohort) were matched 1:2 with those prescribed DMARDs for at least 30 days per year on average (reference cohort), by means of age, gender, and psoriasis duration. Patients prescribed medication of the corresponding cohort for more than 7 days during the observation period were excluded. Cumulative incidences of psychiatric disorders in both cohorts were plotted with the Kaplan-Meier method. The modified Cox regression models were constructed to estimate hazard ratios (HRs). Results: In total, 1,152 and 2,304 patients in the acitretin and the reference cohort, respectively, were included. The 4-year cumulative incidence of overall psychiatric disorders (19.62% vs. 12.06%; p&lt;.001), mood disorders (12.81% vs. 7.67%; p&lt;.001), and psychosis (7.21% vs. 4.63%; p&lt;.001) in the acitretin cohort were significantly higher than those in the reference cohort. Acitretin was independently associated with psychiatric disorders (HR 1.51, 95% confidence interval [CI] 1.23-1.85). The risk is more accentuated in the subgroups of comorbid chronic liver disease (HR 2.60, 95% CI 1.56-4.33) or psoriatic arthritis (HR 3.23, 95% CI 1.75-5.97). Other independent risk factors included insomnia, acute coronary syndrome, females, and age. Conclusions: Compared with disease-modifying antirheumatic drugs, acitretin was associated with higher hazards of psychiatric disorders among psoriasis patients.
DOI: 10.6084/m9.figshare.22316875
title: Supplementary Material for: Risk of psychiatric disorders in patients with psoriasis prescribed acitretin versus disease-modifying antirheumatic drugs: a nationwide matched cohort study

description: Background: Acitretin has been linked to the development of psychiatric disturbance. Objectives: To assess the psychiatric hazards in patients with psoriasis prescribed acitretin compared with those prescribed disease-modifying antirheumatic drugs (DMARDs). Methods: This is a nationwide matched cohort study. From Taiwan’s National Health Insurance Research Database, Adult patients with psoriasis between 1997 and 2013 were screened. Patients prescribed acitretin for at least 30 days per year on average (acitretin cohort) were matched 1:2 with those prescribed DMARDs for at least 30 days per year on average (reference cohort), by means of age, gender, and psoriasis duration. Patients prescribed medication of the corresponding cohort for more than 7 days during the observation period were excluded. Cumulative incidences of psychiatric disorders in both cohorts were plotted with the Kaplan-Meier method. The modified Cox regression models were constructed to estimate hazard ratios (HRs). Results: In total, 1,152 and 2,304 patients in the acitretin and the reference cohort, respectively, were included. The 4-year cumulative incidence of overall psychiatric disorders (19.62% vs. 12.06%; p&lt;.001), mood disorders (12.81% vs. 7.67%; p&lt;.001), and psychosis (7.21% vs. 4.63%; p&lt;.001) in the acitretin cohort were significantly higher than those in the reference cohort. Acitretin was independently associated with psychiatric disorders (HR 1.51, 95% confidence interval [CI] 1.23-1.85). The risk is more accentuated in the subgroups of comorbid chronic liver disease (HR 2.60, 95% CI 1.56-4.33) or psoriatic arthritis (HR 3.23, 95% CI 1.75-5.97). Other independent risk factors included insomnia, acute coronary syndrome, females, and age. Conclusions: Compared with disease-modifying antirheumatic drugs, acitretin was associated with higher hazards of psychiatric disorders among psoriasis patients.
DOI: 10.6084/m9.figshare.22316875.v1
title: Supplementary Material for: Risk of psychiatric disorders in patients with psoriasis prescribed acitretin versus disease-modifying antirheumatic drugs: a nationwide matched cohort study

description: Background: Acitretin has been linked to the development of psychiatric disturbance. Objectives: To assess the psychiatric hazards in patients with psoriasis prescribed acitretin compared with those prescribed disease-modifying antirheumatic drugs (DMARDs). Methods: This is a nationwide matched cohort study. From Taiwan’s National Health Insurance Research Database, Adult patients with psoriasis between 1997 and 2013 were screened. Patients prescribed acitretin for at least 30 days per year on average (acitretin cohort) were matched 1:2 with those prescribed DMARDs for at least 30 days per year on average (reference cohort), by means of age, gender, and psoriasis duration. Patients prescribed medication of the corresponding cohort for more than 7 days during the observation period were excluded. Cumulative incidences of psychiatric disorders in both cohorts were plotted with the Kaplan-Meier method. The modified Cox regression models were constructed to estimate hazard ratios (HRs). Results: In total, 1,152 and 2,304 patients in the acitretin and the reference cohort, respectively, were included. The 4-year cumulative incidence of overall psychiatric disorders (19.62% vs. 12.06%; p&lt;.001), mood disorders (12.81% vs. 7.67%; p&lt;.001), and psychosis (7.21% vs. 4.63%; p&lt;.001) in the acitretin cohort were significantly higher than those in the reference cohort. Acitretin was independently associated with psychiatric disorders (HR 1.51, 95% confidence interval [CI] 1.23-1.85). The risk is more accentuated in the subgroups of comorbid chronic liver disease (HR 2.60, 95% CI 1.56-4.33) or psoriatic arthritis (HR 3.23, 95% CI 1.75-5.97). Other independent risk factors included insomnia, acute coronary syndrome, females, and age. Conclusions: Compared with disease-modifying antirheumatic drugs, acitretin was associated with higher hazards of psychiatric disorders among psoriasis patients.
DOI: 10.4121/ac5073de-34cb-4e71-a9b2-6e2d65e7ae72
title: GreenspaceAccessibility data repository: spatial data underlying the journal paper "Measuring children's and adolescents' accessibility to greenspaces from different locations and commuting settings"

description: This repository contains spatial data on greenspaces, the zones they are accessible to within walking distance, the surrounding road network, surrouding educational facilities and residential environments, and estimated commuting routes between educational and residential environments. This data was collected through Python, using Jupyter Notebooks, and applies to four cities in The Netherlands: Amsterdam, Rotterdam, The Hague, and Delft. For Delft, only greenspaces and the zones they are accessible to are incorporated, as they were collected as additional examples for a side-project to this research.
DOI: 10.6084/m9.figshare.22316890
title: Supplementary Material for: Risk of psychiatric disorders in patients with psoriasis prescribed acitretin versus disease-modifying antirheumatic drugs: a nationwide matched cohort study

description: Background: Acitretin has been linked to the development of psychiatric disturbance. Objectives: To assess the psychiatric hazards in patients with psoriasis prescribed acitretin compared with those prescribed disease-modifying antirheumatic drugs (DMARDs). Methods: This is a nationwide matched cohort study. From Taiwan’s National Health Insurance Research Database, Adult patients with psoriasis between 1997 and 2013 were screened. Patients prescribed acitretin for at least 30 days per year on average (acitretin cohort) were matched 1:2 with those prescribed DMARDs for at least 30 days per year on average (reference cohort), by means of age, gender, and psoriasis duration. Patients prescribed medication of the corresponding cohort for more than 7 days during the observation period were excluded. Cumulative incidences of psychiatric disorders in both cohorts were plotted with the Kaplan-Meier method. The modified Cox regression models were constructed to estimate hazard ratios (HRs). Results: In total, 1,152 and 2,304 patients in the acitretin and the reference cohort, respectively, were included. The 4-year cumulative incidence of overall psychiatric disorders (19.62% vs. 12.06%; p&lt;.001), mood disorders (12.81% vs. 7.67%; p&lt;.001), and psychosis (7.21% vs. 4.63%; p&lt;.001) in the acitretin cohort were significantly higher than those in the reference cohort. Acitretin was independently associated with psychiatric disorders (HR 1.51, 95% confidence interval [CI] 1.23-1.85). The risk is more accentuated in the subgroups of comorbid chronic liver disease (HR 2.60, 95% CI 1.56-4.33) or psoriatic arthritis (HR 3.23, 95% CI 1.75-5.97). Other independent risk factors included insomnia, acute coronary syndrome, females, and age. Conclusions: Compared with disease-modifying antirheumatic drugs, acitretin was associated with higher hazards of psychiatric disorders among psoriasis patients.
DOI: 10.6084/m9.figshare.22316890.v1
title: Supplementary Material for: Risk of psychiatric disorders in patients with psoriasis prescribed acitretin versus disease-modifying antirheumatic drugs: a nationwide matched cohort study

description: Background: Acitretin has been linked to the development of psychiatric disturbance. Objectives: To assess the psychiatric hazards in patients with psoriasis prescribed acitretin compared with those prescribed disease-modifying antirheumatic drugs (DMARDs). Methods: This is a nationwide matched cohort study. From Taiwan’s National Health Insurance Research Database, Adult patients with psoriasis between 1997 and 2013 were screened. Patients prescribed acitretin for at least 30 days per year on average (acitretin cohort) were matched 1:2 with those prescribed DMARDs for at least 30 days per year on average (reference cohort), by means of age, gender, and psoriasis duration. Patients prescribed medication of the corresponding cohort for more than 7 days during the observation period were excluded. Cumulative incidences of psychiatric disorders in both cohorts were plotted with the Kaplan-Meier method. The modified Cox regression models were constructed to estimate hazard ratios (HRs). Results: In total, 1,152 and 2,304 patients in the acitretin and the reference cohort, respectively, were included. The 4-year cumulative incidence of overall psychiatric disorders (19.62% vs. 12.06%; p&lt;.001), mood disorders (12.81% vs. 7.67%; p&lt;.001), and psychosis (7.21% vs. 4.63%; p&lt;.001) in the acitretin cohort were significantly higher than those in the reference cohort. Acitretin was independently associated with psychiatric disorders (HR 1.51, 95% confidence interval [CI] 1.23-1.85). The risk is more accentuated in the subgroups of comorbid chronic liver disease (HR 2.60, 95% CI 1.56-4.33) or psoriatic arthritis (HR 3.23, 95% CI 1.75-5.97). Other independent risk factors included insomnia, acute coronary syndrome, females, and age. Conclusions: Compared with disease-modifying antirheumatic drugs, acitretin was associated with higher hazards of psychiatric disorders among psoriasis patients.
DOI: 10.5519/qd.w9pj6be8
title: Query on the Natural History Museum Data Portal (data.nhm.ac.uk) (311 records)
DOI: 10.25381/cput.22300684
title: APPLICATION OF IEC 61850-90-5 STANDARD-BASED PREDICTIVE DYNAMIC STABILITY SYSTEM

description: The test system adopted in the research study is the Eskom West Grid transmission network. The modified network is a multi-level voltage grid with 400kV running through the transmission lines and voltages of 132kV, 110kV,50kV,33kV,24kV and 16.5kV being the voltages available at the generating station buses. The system comprises of 2 independent power plant (IPPs) of renewable energy supplying the grid when necessary. The grid modelled in compliance with the national regulating standard (NERSA) which allows a per unit deviation of up to 10% from the standard 1.0 p.u in voltages across all buses in the grid. At Palmiet Pump storage generation, a SEL700G relay is placed as main protection for the generators then another SEL-421 relay is optimally placed at the Palmiet 400kV outgoing line to serve as back-up protection to the generator out-of-step protection.
DOI: 10.25381/cput.22300684.v1
title: APPLICATION OF IEC 61850-90-5 STANDARD-BASED PREDICTIVE DYNAMIC STABILITY SYSTEM

description: The test system adopted in the research study is the Eskom West Grid transmission network. The modified network is a multi-level voltage grid with 400kV running through the transmission lines and voltages of 132kV, 110kV,50kV,33kV,24kV and 16.5kV being the voltages available at the generating station buses. The system comprises of 2 independent power plant (IPPs) of renewable energy supplying the grid when necessary. The grid modelled in compliance with the national regulating standard (NERSA) which allows a per unit deviation of up to 10% from the standard 1.0 p.u in voltages across all buses in the grid. At Palmiet Pump storage generation, a SEL700G relay is placed as main protection for the generators then another SEL-421 relay is optimally placed at the Palmiet 400kV outgoing line to serve as back-up protection to the generator out-of-step protection.
DOI: 10.25381/cput.22300609
title: A Novel Optimisation Method For Voltage And Reactive Power Control Of Electric Power Systems

description: Power system data used in the study of the design and development of algorithms for voltage and reactive power control of electric power systems.
DOI: 10.25381/cput.22300609.v1
title: A Novel Optimisation Method For Voltage And Reactive Power Control Of Electric Power Systems

description: Power system data used in the study of the design and development of algorithms for voltage and reactive power control of electric power systems.
DOI: 10.34740/kaggle/dsv/4022961
title: Cup_mug_dataset
DOI: 10.25550/2w-rs08
title: Transgenic mouse model DNA cassette to study CX43 effect on enamel organ

description: The enamel of 8-week-old _Odam/ CX43 f/f_ mice, that have _CX43_ silenced in the enamel organ, was analyzed using microCT
DOI: 10.5255/ukda-sn-856375
title: Public Memory of the Sochi 2014 and Russia 2018 Tournaments and Their Mediation, 2022

description: The goal of this data collection is to help assess how the Russian sport mega-events of the 2010s, the Sochi Olympics and the 2018 World Cup, are publicly remembered and what does this suggest about the outcomes of Russia's efforts to influence domestic and international audiences through such projects several years after their conclusion. The collection is comprised of three sets of research:(i) follow-up Interviews with Russian fans and media specialists; (ii) Twitter data related to memory of Sochi 2014 following the outbreak of the Russo-Ukraine war; and (iii) Twitter data related to memory of Sochi 2014 and Russia 2018 Football World Cup.
DOI: 10.6084/m9.figshare.22316929
title: New QoI resistance mechanisms in T. urticae

description: Lu et al. (2023) has uncovered that increased metabolism in combination with the novel cytochrome b target-site mutation L258F confers cross-resistance between the Qo inhibitors acequinocyl and bifenazate in <em>Tetranychus urticae</em>. The Supplementary Data for Lu et al. (2023) comprises: Data S1: raw read count data used for differential expression analysis
DOI: 10.6084/m9.figshare.22316929.v1
title: New QoI resistance mechanisms in T. urticae

description: Lu et al. (2023) has uncovered that increased metabolism in combination with the novel cytochrome b target-site mutation L258F confers cross-resistance between the Qo inhibitors acequinocyl and bifenazate in <em>Tetranychus urticae</em>. The Supplementary Data for Lu et al. (2023) comprises: Data S1: raw read count data used for differential expression analysis
DOI: 10.17031/641add8f308e0
title: North Sea selected groups

description: Same methodology as last time - however note that due to a slightly different method with collated total diatoms and dinoflagellates, indication of presence only can now be multiples of 0.0000000001 (ie if there were a three diatom taxa recorded as present only, and no other diatoms, you could get values of 0.0000000003 - this should still be treated as presence only).
DOI: 10.5281/zenodo.6472442
title: data_upload_test

description: first zenodo test with two datasets: <strong>test_data1.csv</strong> and <strong>test_data2.csv</strong>
DOI: 10.5281/zenodo.6472469
title: data_upload_test

description: first zenodo test with two datasets: <strong>test_data1.csv</strong> and <strong>test_data2.csv</strong>
DOI: 10.5281/zenodo.6472477
title: data_upload_test

description: first zenodo test with: <strong>test_data0.csv</strong> <strong>test_data1.csv</strong> <strong>test_data2.csv</strong> <strong>test_data3.csv</strong>
DOI: 10.5281/zenodo.6472486
title: data_upload_test

description: first zenodo test with: <strong>test_data0.csv</strong> <strong>test_data1.csv</strong> <strong>test_data2.csv</strong> <strong>test_data3.csv</strong> <strong>test_data4.csv</strong>
DOI: 10.5281/zenodo.6472499
title: data_upload_test

description: <em>README here with table description</em> first zenodo test with: test_data0.csv (<em>best so far</em>) test_data1.csv test_data2.csv test_data3.csv test_data4.csv test_data5.csv
description: Copyright (c) 2022 - CMCC
DOI: 10.5281/zenodo.6472910
title: data_upload_test

description: ✉️ G. Mannarini<sup>1,*</sup> ✉️ M.L. Salinas<sup>1</sup> ✉️ A. Salhi<sup>1</sup> Dataset obtained processing the data collected by GUTTA LP for Deliverable 1.2.6. Meaning of the variables in the GUTTA_D126_CO2_DB dataset: column name description unit leg_voyage String that identifies start and arrival locations of a specific voyage leg date Date of the trip transp_mean Transportation mean used to travel ferry_IMOn The International Maritime Organization (IMO) number (only for ferry) distance Traveled distance [km] CO2 Leg-related CO2 emissions [ton] leg_num Leg ordered number in the full voyage correction_factor Number of people that shared the transportation mean (only for cars) voyage_destination Event destination voyage_date_and_dest String that identifies voyage destination and date voyage_itinerary Complete voyage itinerary nlegs Total number of legs that compose the voyage affiliation Traveller's affiliation Read [this document](docu.zenodo.link) for further details. <sup>1</sup>CMCC Foundation
description: Copyright (c) Fondazione CMCC, 2022 - ERDF through Italy-Croatia Interreg Programme: 10043587 (GUTTA)
DOI: 10.5281/zenodo.6907705
title: data_upload_test

description: ✉️ G. Mannarini<sup>1,*</sup> ✉️ M.L. Salinas<sup>1</sup> ✉️ A. Salhi<sup>1</sup> Dataset obtained processing the data collected by GUTTA LP for Deliverable 1.2.6. Meaning of the variables in the GUTTA_D126_CO2_DB dataset: column name description unit leg_voyage String that identifies start and arrival locations of a specific voyage leg date Date of the trip transp_mean Transportation mean used to travel ferry_IMOn The International Maritime Organization (IMO) number (only for ferry) distance Traveled distance [km] CO2 Leg-related CO2 emissions [ton] leg_num Leg ordered number in the full voyage correction_factor Number of people that shared the transportation mean (only for cars) voyage_destination Event destination voyage_date_and_dest String that identifies voyage destination and date voyage_itinerary Complete voyage itinerary nlegs Total number of legs that compose the voyage affiliation Traveller's affiliation Read [this document](docu.zenodo.link) for further details. <sup>1</sup>CMCC Foundation
description: Copyright (c) Fondazione CMCC, 2022 - ERDF through Italy-Croatia Interreg Programme: 10043587 (GUTTA)
DOI: 10.5281/zenodo.6907873
title: data_upload_test

description: ✉️ G. Mannarini<sup>1,*</sup> ✉️ M.L. Salinas<sup>1</sup> ✉️ A. Salhi<sup>1</sup> Dataset obtained processing the data collected by GUTTA LP for Deliverable 1.2.6. Meaning of the variables in the GUTTA_D126_CO2_DB dataset: column name description unit voyage_date Date of the trip in the format YYYYMM voyage_dest Event destination affiliation Traveller's affiliation leg_num Leg ordered number in the full voyage leg_voyage String that identifies start and arrival locations of a specific voyage leg transp_mean Transportation mean used to travel ferry_IMOn The International Maritime Organization (IMO) number (only for ferry) car_occupancy Number of people that shared the car (only for car) distance Traveled distance [km] CO2 Leg-related CO2 emissions [ton] Read [this document](docu.zenodo.link) for further details. <sup>1</sup>CMCC Foundation
description: Copyright (c) Fondazione CMCC, 2022 - ERDF through Italy-Croatia Interreg Programme: 10043587 (GUTTA)
DOI: 10.25345/c5gx4546f
title: MassIVE MSV000091524 - Proteomic characterization of peripheral nerve injury
title: Peripheral nerve injury induces a profound remodelling of protein networks and cellular architecture. Many studies investigated transcriptomic changes and and alterations of specific proteins and signalling pathways during peripheral nerve de-and regeneration. However, an unbiased in-depth proteomic characterization of whole nerve proteomes has not been performed so far. Hence, the aim of this proteomics experiment was to define proteome changes at two time points after a peripheral nerve crush injury in C57BL6/J mice: 7 days post injury, which is a timepoint at which nerve degeneration is ongoing and 28 days post injury which is a timepoint at which nerve regeneration already takes place.
DOI: 10.4121/22294423
title: Data underlying the publication: Maximizing wind farm power output with the helix approach – experimental validation and wake analysis using tomographic PIV

description: This data set contains phase-averaged measurements of a scaled model wind turbine wake, acquired using tomographic piv. Three control settings of the turbine were compared: normal operation (baseline), the clockwise helix approach, and the counter-clockwise helix approach. Measurements of the upstream and downstream turbine are included as well.
DOI: 10.4121/e7ec260e-e7f2-47c6-9cd5-4241295c9cf9.v1
title: Data underlying the publication: Maximizing wind farm power output with the helix approach – experimental validation and wake analysis using tomographic PIV

description: This data set contains phase-averaged measurements of a scaled model wind turbine wake, acquired using tomographic piv. Three control settings of the turbine were compared: normal operation (baseline), the clockwise helix approach, and the counter-clockwise helix approach. Measurements of the upstream and downstream turbine are included as well.
DOI: 10.6084/m9.figshare.22317019
title: Supporting information.xlsx

description: Supporting information to accompany 'Who applies for energy grants' in Energy Research and Social Science
DOI: 10.6084/m9.figshare.22317019.v1
title: Supporting information.xlsx

description: Supporting information to accompany 'Who applies for energy grants' in Energy Research and Social Science
DOI: 10.4121/e7ec260e-e7f2-47c6-9cd5-4241295c9cf9
title: Data underlying the publication: Maximizing wind farm power output with the helix approach – experimental validation and wake analysis using tomographic PIV

description: This data set contains phase-averaged measurements of a scaled model wind turbine wake, acquired using tomographic piv. Three control settings of the turbine were compared: normal operation (baseline), the clockwise helix approach, and the counter-clockwise helix approach. Measurements of the upstream and downstream turbine are included as well.